Risk Prevention Program and Therapeutic Patient Education Program of Patients With Uncontrolled Epilepsy

ConditionEpilepsy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorUniversity Hospital, Montpellier

About this trial

Pilot, controled, randomized study aiming to evaluate a plan for the prevention of risks related to epilepsy, 3 months after the last therapeutic patient education session. Two groups of patients will be compared: group "intervention" (consultation with the neurologist then a psychologist followed by a session dedicated to risk prevention ("Recognize and Manage risks") integrated into usual Therapeutic Patient Education (TPE) versus "control" group (usual consultations with the neurologist and usual TPE).

37 subjects per group will be included in this study.

Eligibility criteria

Qualifiers

Patient between 18 and 60 years old

Patient with poorly controlled epilepsy (persistence of seizures evolving for more than a year despite proper treatment) or patient seizure-free for over a year but for whom therapeutic patient education (TPE) would be beneficial according to the investigator..

Patient agreeing to participate in a therapeutic education program (TPE)

Disqualifiers

Epileptic patient who has already benefited from a TPE epilepsy program

Patients with major cognitive impairment

Patient under guardianship or legal protection (safeguard of justice)

Pregnant or breast-feeding women

Trial design

Treatments tested in this trial

  • Risk prevention session
  • Usual Therapeutic Patient Education (TPE) management

Treatment groups

74 Participants
are divided into 2 treatment groups